The Importance of Dosing, Timing, and (in)Activation of Adipose Tissue-Derived Mesenchymal Stromal Cells on Their Immunomodulatory Effects
- 1 January 2020
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 29 (1) , 38-48
Abstract
Mesenchymal stromal cells (MSC) are attractive candidates for immunomodulatory cell therapy. However, it remains unknown in how far therapeutic efficacy and potency are dependent on the dosage and activity of the MSC. We previously observed that infusion of MSC leads to rapid and transient changes in cytokine expression in blood, lung and liver. In the present study, increasing doses of syngeneic adipose tissue-derived MSC were infused in healthy mice and systemic changes in G-CSF, IL6, IL-10 and CXCL5 were detected two hours after administration of 3x105 MSC per animal, but not at lower doses. In lung and liver tissue, dose-dependent effects of MSC on cytokine mRNA expression levels were detected from doses as low as 3x103 MSC. Infusion of secretome-deficient or IFNγ-activated MSC in healthy mice had similar effects on systemic cytokine levels as control MSC, suggesting that in vivo at least the initial systemic effect of MSC administration is independent of the level of activity of MSC but depends on the response of host cells to MSC. The results of this study reveal a rapid dose-dependent effect of MSC and stress the important role of host cells in MSC treatment. This knowledge contributes to the design of rational MSC trials and to the quest for clinical efficacy of MSC therapy.Keywords
This publication has 39 references indexed in Scilit:
- Human Umbilical Cord Mesenchymal Stem Cell Therapy for Patients with Active Rheumatoid Arthritis: Safety and EfficacyStem Cells and Development, 2013
- Mesenchymal Stem Cells Induce an Inflammatory Response After Intravenous InfusionStem Cells and Development, 2013
- Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic CardiomyopathyJAMA, 2012
- Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney TransplantsJAMA, 2012
- Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patientsJournal of Gastroenterology and Hepatology, 2012
- Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use StudyTransplantation and Cellular Therapy, 2011
- Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental ColitisThe Journal of Immunology, 2009
- Mesenchymal stem cells as trophic mediatorsJournal of Cellular Biochemistry, 2006
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyBlood, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004